The SEC has accused SolarWinds and its CISO Timothy Brown of fraud and disclosure control violations, marking its first formal action against a CISO. The SEC alleges SolarWinds and Brown made misstatements regarding cybersecurity in its SEC filings and on its website. This action underscores the SEC’s increased focus on cybersecurity disclosures following new rules for public companies. The complaint also alleges SolarWinds did not report potentially material cybersecurity risks.
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
